Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company Participants Jeff Hackman - CEO Pierre S. Sayad - Chief Medical Officer Robert Andrade - CFO Conference Call Participants Chase Knickerbocker - Senior Research Analyst Madison El-Saadi - Healthcare Equity Research Analyst Raghuram Selvaraju - Managing Director and Equity Research Analyst None - Analyst None - Analyst Operator Good morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter an ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJeffrey S. Hackman - CEOPierre S. Sayad - CMORobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystSudhanva Nathan - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year ...